These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15846499)

  • 1. Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer.
    Onodera H; Mori A; Nagayama S; Fujimoto A; Tachibana T; Yonenaga Y; Tsuruyama T
    Int J Colorectal Dis; 2005 Nov; 20(6):477-84. PubMed ID: 15846499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases?
    Weber JC; Nakano H; Bachellier P; Oussoultzoglou E; Inoue K; Shimura H; Wolf P; Chenard-Neu MP; Jaeck D
    Am J Surg; 2001 Jul; 182(1):81-8. PubMed ID: 11532423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer.
    Nagashima I; Oka T; Hamada C; Naruse K; Osada T; Muto T
    Am J Gastroenterol; 1999 Mar; 94(3):739-43. PubMed ID: 10086660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic prognostic factors in resected colorectal lung metastases.
    Shiono S; Ishii G; Nagai K; Yoshida J; Nishimura M; Murata Y; Tsuta K; Nishiwaki Y; Kodama T; Ochiai A
    Ann Thorac Surg; 2005 Jan; 79(1):278-82; discussion 283. PubMed ID: 15620957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and multivariate analysis of colorectal cancer with liver metastasis.
    Wang Y; Duan B; Shen C; Wu B; Luo J; Zhao G
    Hepatogastroenterology; 2014 Sep; 61(134):1568-73. PubMed ID: 25436344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases.
    Joechle K; Moser C; Ruemmele P; Schmidt KM; Werner JM; Geissler EK; Schlitt HJ; Lang SA
    World J Surg Oncol; 2017 Mar; 15(1):57. PubMed ID: 28270160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of clinical and pathologic risk factors in liver resection for hepatic colorectal metastases.
    Zhou L; Zhag G; Tang T; Lian R; Wang W
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S178-82. PubMed ID: 24516057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma.
    Imamura H; Matsuyama Y; Shimada R; Kubota M; Nakayama A; Kobayashi A; Kitamura H; Ikegami T; Miyagawa SI; Kawasaki S
    Am J Gastroenterol; 2001 Nov; 96(11):3178-84. PubMed ID: 11721768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
    Eefsen RL; Engelholm L; Willemoe GL; Van den Eynden GG; Laerum OD; Christensen IJ; Rolff HC; Høyer-Hansen G; Osterlind K; Vainer B; Illemann M
    Int J Cancer; 2016 Apr; 138(7):1777-84. PubMed ID: 26510166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?
    Yan DB; Clingan P; Morris DL
    Cancer; 2003 Jul; 98(2):320-30. PubMed ID: 12872352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases.
    Yoshidome H; Kohno H; Shida T; Kimura F; Shimizu H; Ohtsuka M; Nakatani Y; Miyazaki M
    Int J Oncol; 2009 Apr; 34(4):923-30. PubMed ID: 19287949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
    J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.